DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MVT-1075
1
Unknown
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
MVT-1075
×
Maximum Phase:
1
First Approval:
None
UNII:
473BOU89F3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1059615
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
GSK-1059615
×
Maximum Phase:
1
First Approval:
None
UNII:
07YMO87363
Molecule Type:
Small molecule
Molecular Formula:
C18H11N3O2S
Molecular Weight:
333.37
AlogP:
3.62
PSA:
71.95
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BMS-936559
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
BMS-936559
×
Maximum Phase:
1
First Approval:
None
UNII:
TLZ6R6973Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGN-4659
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
REGN-4659
×
Maximum Phase:
1
First Approval:
None
UNII:
6CGQ1X5Y6V
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACY-241
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACY-241
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-779788
1
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis
LXR-beta agonist
BMS-779788
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TANIBORBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections; Pyelonephritis
Unknown
TANIBORBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
8IGQ156Z07
Molecule Type:
Small molecule
Molecular Formula:
C19H28BN3O5
Molecular Weight:
389.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AGS62P1
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AGS62P1
×
Maximum Phase:
1
First Approval:
None
UNII:
37I4D4Q7S2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUTANE
1
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension
Unknown
BUTANE
×
Maximum Phase:
1
First Approval:
None
UNII:
6LV4FOR43R
Molecule Type:
Small molecule
Molecular Formula:
C4H10
Molecular Weight:
58.12
AlogP:
1.81
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LY-2874455
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor inhibitor
LY-2874455
×
Maximum Phase:
1
First Approval:
None
UNII:
E9M363811V
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2N5O2
Molecular Weight:
444.32
AlogP:
4.76
PSA:
88.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AN-2718
1
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis
Unknown
AN-2718
×
Maximum Phase:
1
First Approval:
None
UNII:
810U6C2DGG
Molecule Type:
Small molecule
Molecular Formula:
C7H6BClO2
Molecular Weight:
168.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
2'-FUCOSYLLACTOSE
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative; Crohn Disease
Unknown
2'-FUCOSYLLACTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
XO2533XO8R
Molecule Type:
Small molecule
Molecular Formula:
C18H32O15
Molecular Weight:
488.44
AlogP:
-6.7
PSA:
256.29
HBD:
10.0
HBA:
#RotB:
10.0
Source:
SIBROTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Fibroblast activation protein alpha binding agent
SIBROTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
552U6E1NIW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-164
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-164
×
Maximum Phase:
1
First Approval:
None
UNII:
QCA97P3GSS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PIDACMERAN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PIDACMERAN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIGULIXOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TIGULIXOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BMS-817378
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
BMS-817378
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-KYNURENINE
1
Small molecule
Investigational
Unknown
Unknown
Headache
Unknown
L-KYNURENINE
×
Maximum Phase:
1
First Approval:
None
UNII:
02JW4J5R44
Molecule Type:
Small molecule
Molecular Formula:
C10H12N2O3
Molecular Weight:
208.22
AlogP:
0.25
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TP-271
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections; Pneumonia
Unknown
TP-271
×
Maximum Phase:
1
First Approval:
None
UNII:
Y6IUM7395Q
Molecule Type:
Small molecule
Molecular Formula:
C27H31FN4O8
Molecular Weight:
558.56
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
4.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CTT-1057
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
CTT-1057
×
Maximum Phase:
1
First Approval:
None
UNII:
QMH3V8VSPB
Molecule Type:
Small molecule
Molecular Formula:
C28H40FN4O14P
Molecular Weight:
706.61
AlogP:
0.84
PSA:
295.06
HBD:
9.0
HBA:
#RotB:
25.0
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DANAVOREXTON
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Hypersomnia; Narcolepsy; Sleep Apnea, Obstructive
Unknown
DANAVOREXTON
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H32N2O5S
Molecular Weight:
424.56
AlogP:
2.88
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD3514
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
AZD3514
×
Maximum Phase:
1
First Approval:
None
UNII:
127DSS8X7J
Molecule Type:
Small molecule
Molecular Formula:
C25H32F3N7O2
Molecular Weight:
519.57
AlogP:
2.83
PSA:
79.09
HBD:
0.0
HBA:
#RotB:
5.0
Source:
REN-001
1
Unknown
Investigational
Unknown
Unknown
Muscular Atrophy
Unknown
REN-001
×
Maximum Phase:
1
First Approval:
None
UNII:
XRP79L5C2X
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VADASTUXIMAB TALIRINE
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes
Unknown
VADASTUXIMAB TALIRINE
×
Maximum Phase:
1
First Approval:
None
UNII:
T13V17U431
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H14N4O2+2
Molecular Weight:
258.28
AlogP:
0.38
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
117
118
119
120
121
122
123
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA